Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Redeye initiates coverage of Asarina Pharma

We initiate coverage of Asarina Pharma, a mid-stage biotech company in the field of women’s health and neurology. With an initial proof-of-concept achieved, we see good prospects for demonstrating strong efficacy and safety with its lead candidate – sepranolone - in the ongoing phase IIb trial (n=225) in the debilitating women’s health disorder; premenstrual dysphoric disorder (PMDD). Top-line results are expected in Q1 20. A compelling case also includes a strong and long-term oriented ownership base that should enable Asarina Pharma to retain a significant portion of the future cash

Cancellation of a concession in Buenos Aires

A court in Argentina has canceled a vehicle inspection concession awarded to Inspecentro S.A. in Buenos Aires (Inspecentro Buenos Aires), a business in which Opus had assumed control via an agreement. Since Inspecentro Buenos Aires has not yet started operating, there is no impact on Opus revenues in Argentina. However, a write-down of fixed assets may be required. Opus is evaluating legal options to appeal or possibly seek compensation.In July 2017, Opus entered into an agreement with the Portuguese vehicle inspection company Inspecentro – Inspeccao Periodica de Veiculos Automoveis, S.A.,

InDex Pharmaceuticals meets primary endpoint in the phase IIb study CONDUCT with cobitolimod in ulcerative colitis

· Outstanding combination of efficacy and safety · 15% delta vs. placebo for clinical remission August 27, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced positive top line results from the dose optimisation study CONDUCT, which is evaluating cobitolimod for the treatment of moderate to severe ulcerative colitis. The study met the primary endpoint of clinical remission, demonstrating a superior efficacy of 15% (delta) in patients receiving the highest dose of cobitolimod compared to placebo. Cobitolimod was well tolerated at all dose levels and no differences in the

505 Games, Remedy Entertainment’s critically acclaimed “Control” launches today on PC, PS4, Xbox One

Remedy Entertainment Plc | Press release 08:00 am (EET) 27 August 2019 505 Games, Remedy Entertainment’s critically acclaimed “Control” launches today on PC, PS4, Xbox One Supernatural action-adventure game now available at physical and digital retail.Watch the launch trailer here: https://www.youtube.com/watch?v=9QkLwj66bM0  Global videogame publisher 505 Games 

Nordic Outlook: Muted global growth amid extreme yields

Press releaseStockholm, August 27, 2019 Nordic Outlook: Muted global growth amid extreme yields Sweden: Riksbank on hold despite low inflation The global economy is seeing a noticeably pessimistic bond market and increased uncertainty due to trade and geopolitical issues. A lengthy manufacturing slump and escalating trade wars will cause yearly global growth to slow from nearly 4 per cent in 2018 to just over 3 per cent during the period 2019-2021. Yet our main scenario is still that outright recession will be avoided. Moderate debt is lowering the risk of contagion from the weak

Norway Royal Salmon: Q2 19 – Operational EBIT of MNOK 116

Today Norway Royal Salmon (NRS) reports an operational EBIT of MNOK 116 for the second quarter 2019 and EBIT per kg of NOK 23.95. Corresponding figures for the same quarter last year were MNOK 181 and NOK 24.39. - We are pleased with the result for the quarter in our main region, Region North. Region South has harvested from the same site as in the previous quarter, with announced high production costs. NRS shall grow through sustainable growth, and the Group’s biomass has increased 26 % in comparison to the end of the same quarter last year. NRS had good price achievement and the sales

BAKKAFROST: Share Savings Plan Transaction

As a part of the share savings plan for employees in 2019, the following primary insiders have purchased Bakkafrost shares: Regin Jacobsen, CEO, purchased 25 shares. After the transaction, he holds 4,495,871 shares. Odd Eliasen, Managing Director, purchased 16 shares. After the transaction, he holds 173,575 shares. Høgni Dahl Jakobsen, CFO, purchased 15 shares. After the transaction, he holds 82 shares. Annika Frederiksberg, Board Member, purchased 7 shares. After the transaction, she holds directly and indirectly 15,785 shares. The shares were purchased from P/F Bakkafrost

Communique from the Extraordinary General Meeting of CELLINK AB (publ)

The following is a summary of the decision made by the Extraordinary General Meeting “EGM”. · The EGM resolved on a new issue of shares in accordance with the Board's proposal for the EGM. The decision: · The EGM resolved on a new issue of 674,678 Class B shares, resulting in an increase in the share capital by a maximum of SEK 67,467.80. · The right to subscribe for the new shares shall be given to Christian Wildmoser, 79,623 shares, Benjamin Steimle, 42,610 shares, Andre Gross, 74,542 shares, Jonas Schöndube, 74,542 shares, Jürg F. Geigy, 110,531 shares, Peter Koltay, 28,

Interim Financial Report - Second quarter 2019

Q2 2019 financial performanceThe second quarter (Q2) 2019 consolidated financial statement describes the results of the Scan Bidco A/S Group. ·  The Q2 2019 revenue was DKK 1,026m and increased by 17.3% vs Q2 2018. ·  The Q2 2019 Gross Profit was DKK 186m and the Gross Margin equals 18.2%. ·  The Q2 2019 EBITDA before special items amounts to DKK 43m. ·  The Q2 2019 Adjusted EBITDA (Business performance*) excluding the impact of IFRS 16 Leases amounts to DKK 34m (H1 2019: DKK 63m). *Business performance represents the underlying financial performance of the Group in the

Presentation of Second Quarter 2019 Financials

Funcom 2Q19 report Funcom 2Q19 presentation Financials  · Revenue for the quarter increased 53% from 1Q19 to USD 8 876 thousand   · EBITDA increased 72% from 1Q19 to USD 4 372 thousand. The 12-month rolling EBITDA margin at 2Q19 was 53%, close to the highest in Funcom’s history    · EBIT increased to USD 594 thousand from USD 128 thousand in 1Q19   · The equity increased 4% from 1Q19 to USD 47 639 thousand  · The cash position

CEO Karl-Henrik Sundström leaves Stora Enso in 2020

STORA ENSO OYJ INSIDER INFORMATION 26 August 2019 at 20.20 EESTKarl-Henrik Sundström has informed Stora Enso’s Board of Directors today that he is leaving the position of CEO. The Board has initiated the search process for a successor.Karl-Henrik Sundström will continue in his current role for the time being and will leave Stora Enso during the first quarter of 2020. The exact date will be communicated once a successor is in place.“Under Karl-Henrik Sundström’s leadership and vision, Stora Enso has accelerated the transformation into the bioeconomy. He has played a crucial role in

Ossur Hf : Transactions in relation to share buyback program

Announcement no. 49/201926 August 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 31 December 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The

YIT Corporation: SHARE REPURCHASE 26.8.2019

YIT   Corporation ANNOUNCEMENT 26.8.2019 YIT   Corporation: SHARE REPURCHASE 26.8.2019 In the Helsinki Stock   Exchange Trade date          26.8.2019Bourse trade        BuyShare                  YITAmount            50 000 SharesAverage price/ share    5.0477 EURTotal cost            252 385.00 EUR YIT   Corporation now holds a total of 2 172 783 sharesincluding   the shares repurchased on 26.8.2019 On behalf of YIT Corporation Nordea Bank Oyj

First Brazilian Gripen E Completes its First Flight

Saab today completed a successful first flight with the first Brazilian Gripen E fighter aircraft, 39-6001. At 2.41 pm CET on August 26, the Gripen E aircraft took off on its maiden flight flown by Saab test pilot Richard Ljungberg. The aircraft operated from Saab´s airfield in Linköping, Sweden.The duration of the flight was 65 minutes and included test points to verify basic handling and flying qualities at different altitudes and speeds. The main purpose was to verify that the aircraft behavior was according to expectations. “This milestone is a testament to the great partnership

Press release: Online multiplayer and new release date for Conan Chop Chop

In today's press release publisher Funcom and developer Mighty Kingdom announce that the game based on the Conan the Barbarian IP, Conan Chop Chop, will be expanded to include Online Multiplayer in addition to the already revealed Couch Co-op Multiplayer. To allow for this extended investment, the game release is moved from 3 September 2019, as previously announced, to 1Q 2020. The game will be available digitally on PC, PlayStation 4, Xbox One and Nintendo Switch. To read the full press release please visit the news section of the Funcom website .

Results from comparative animal experimental study on the effects of its candidate substance Libiguin® DIC2024 versus the active substance in Viagra®

Press release: Uppsala, August 26, 2019. Dicot AB (publ), developer of drugs targeting sexual dysfunctions­­­­­, today announced that the company has conducted a comparative animal experimental study on the effects of its candidate substance Libiguin® DIC2024 versus the active substance in Viagra®, namely sildenafil, the latter which belongs to the substance group PDE-5 inhibitors used for treatment of erectile dysfunction. The compounds were administered to male rats, which were then introduced to female rats, who had been made sexually receptive by treatment with sex hormones (estrogen

#19-1024 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Interim Report January-June 2019 Bluestep Bank AB

Profit for the period compared with the same period the previous year The Group’s net profit for the period amounted to SEK 109m (SEK 91m), corresponding to an increase of 20%. The increase is mainly attributable to increased interest income. The Group’s operating profit before tax amounted to SEK 137m (SEK 117m). Net interest income The Groups net interest income increased by 13% compared to the same period the previous year, to SEK 395m (SEK 348m). The increase is attributable to volume growth in lending to the public. Operating expenses The Group’s expenses increased by 10%

Successful placement of new hybrid capital

Ocean Yield ASA (“the Company”) has successfully completed a new perpetual hybrid callable bond (“Hybrid Bond”) issue of USD 125 million, carrying a coupon of 3 months LIBOR + 6.50 % p.a. with quarterly interest payments. The Hybrid Bond issue attracted strong interest and was well oversubscribed. The net proceeds from the Hybrid Bond will be used for general corporate purposes including new investments. The Hybrid Bond will be accounted for as book equity and is subordinated to the Company’s outstanding senior unsecured bonds. Arctic Securities AS, DNB Markets, Nordea Bank, Pareto

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release August 26, 2019, at 3:40 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on August 26, 2019, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on August 23, 2019. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+-----------

Vestas provides tailored EPC wind energy solution for challenging industrial site in Germany

News release from Vestas Northern and Central EuropeHamburg, 26 August 2019 An order for a 29 MW wind power plant from Avacon Natur GmbH, a subsidiary of German utility E.ON SE,  has underlined Vestas’ ability to provide a site-specific solution for a challenging site that requires both careful planning and installation as well as measures to ensure safe operation in a busy industrial environment. The seven V136-4.2 MW wind turbines at a hub height of 166m – the tallest standard towers currently offered by Vestas – provide excellent energy production for the project, which is

Elkem ASA acquires Basel Chemie

Elkem ASA acquires Basel Chemie, a Korean producer of specialty silicone gels for cosmetics and water repellents for the construction industry. The acquisition gives Elkem access to leading technology in attractive end-user silicone segments and provides a solid platform for further development and growth.Basel Chemie  was founded in 1999 and has a state-of-the-art plant near Gunsan and a new research and development and office centre in Seoul. The company has 32 employees and had an annual turnover of USD 7.7 million in 2018 and an average EBITDA margin of

There are no items matching the current filter
There are no more items matching the current filter
Back to top